A case of reactivation of varicella–zoster virus after BNT162b2 vaccine second dose?

We report a case of itchy papulovesicular rash consistent with varicella–zoster virus reactivation after Pfizer-BioNTech vaccine second dose administration. While there have been cases of varicella–zoster virus reactivation due to COVID-19 or COVID-19 vaccine inoculation in older individuals with pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Santovito, Luca Spiro, Pinna, Graziano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364300/
https://www.ncbi.nlm.nih.gov/pubmed/34390376
http://dx.doi.org/10.1007/s00011-021-01491-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364300/
https://www.ncbi.nlm.nih.gov/pubmed/34390376
http://dx.doi.org/10.1007/s00011-021-01491-w

Ejemplares similares